OneMedNet Corp (ONMD) · Oct 14, 2026 · Other events
Nasdaq compliance restored — 10 consecutive sessions above the $1.00 minimum bid
OneMedNet’s Nasdaq compliance notice removes its minimum-bid listing overhang, but adds no new operating or commercial information.
OneMedNet is commercializing an AI-driven, imaging-centric real-world-data platform for life-science customers, with recent commercial momentum including more than $3 million in 2026 bookings. This filing removes a listing-risk overhang, not an operating one. Nasdaq confirmed that the company regained compliance after its closing bid price stayed at or above $1.00 for 10 consecutive business days from September 29 through October 12, 2026.
The result is largely procedural and partly anticipated. The company had already disclosed the April deficiency notice and had until October 12, 2026 to cure it; this filing confirms that the cure succeeded and that the matter is closed. It improves certainty around continued Nasdaq listing, but says nothing about revenue, bookings conversion, cash, or execution of the data-platform strategy.
Bottom line: OneMedNet cleared an important administrative hurdle, but the filing does not change the underlying business story or provide a new fundamental catalyst. </analysis>
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!